AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gemprime M 0.5mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Crassula Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Gemprime M 0.5mg/500mg Tablet SR

Diabetic patients using the extended-release Gemprime M 0.5mg/500mg tablet, an antidiabetic medication, manage type 2 diabetes through this dual-action formulation. This combination therapy regulates blood glucose effectively when taken with meals, consistently at the same time daily for optimal results. Dosage is personalized by your physician, adjusted based on blood sugar monitoring. Continuous use is crucial; premature discontinuation, without physician consultation, risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a holistic approach including dietary modifications, exercise, and weight management as advised by your doctor. Commonly reported is hypoglycemia (low blood sugar), identifiable by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is vital. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior heart conditions necessitate consultation with your doctor before initiating treatment. Pregnant or lactating individuals should consult their physician. Regular blood glucose monitoring is essential; additional blood tests may be recommended to assess blood cell counts and liver function.

Primary Ingredients of Gemprime M 0.5mg/500mg Tablet SR

No text was provided to rewrite.

Uses of Gemprime M 0.5mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Gemprime M 0.5mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gemprime M 0.5mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Gemprime M 0.5mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gemprime M 0.5mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Gemprime M 0.5mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Gemprime M 0.5mg/500mg Tablet SR works:

Gemprime M SR tablets (0.5mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gemprime M 0.5mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gemprime M 0.5mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Gemprime M tablets (0.5mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gemprime M 0.5mg/500mg SR tablets, potentially requiring dosage modification. Medical advice is essential. The medication is contraindicated for those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gemprime M 0.5mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; Gemprime M 0.5mg/500mg SR tablets are contraindicated in patients with severe liver disease.

What if you forget to take Gemprime M 0.5mg/500mg Tablet SR :

Should you forget to take a Gemprime M 0.5mg/500mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gemprime M 0.5mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gemprime M 0.5mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Gemprime M 0.5mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gemprime M 0.5mg/500mg Tablet SR and seek immediate medical attention.
Gemprime M 0.5mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Gemprime M 0.5mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Gemprime M 0.5mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Gemprime M 0.5mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gemprime M 0.5mg/500mg SR tablets and alcohol is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Gemprime M 0.5mg/500mg Ta...
31
MRP 38
18% off